Thompson Travis Alvin (CIK 1983944) reported 13 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2026-07-07). Recent activity: Sell BCYC (104 shares), Sell BCYC (819 shares), Sell BCYC (799 shares), Sell BCYC (102 shares), Buy BCYC (37,500 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-07-07 | BICYCLE THERAPEUTICS PLC (BCYC) | Chief Financial Officer | Sell | 104 | $448 |
| 2026-07-07 | BICYCLE THERAPEUTICS PLC (BCYC) | Chief Financial Officer | Sell | 819 | $3,497 |
| 2026-04-06 | BICYCLE THERAPEUTICS PLC (BCYC) | Chief Financial Officer | Sell | 799 | $3,923 |
| 2026-04-06 | BICYCLE THERAPEUTICS PLC (BCYC) | Chief Financial Officer | Sell | 102 | $515 |
| 2026-01-06 | BICYCLE THERAPEUTICS PLC (BCYC) | CHIEF ACCOUNTING OFFICER | Buy | 37,500 | $0 |
| 2026-01-06 | BICYCLE THERAPEUTICS PLC (BCYC) | CHIEF ACCOUNTING OFFICER | Sell | 1,317 | $8,956 |
| 2026-01-06 | BICYCLE THERAPEUTICS PLC (BCYC) | CHIEF ACCOUNTING OFFICER | Sell | 1,115 | $7,192 |
| 2025-10-06 | BICYCLE THERAPEUTICS PLC (BCYC) | CHIEF ACCOUNTING OFFICER | Sell | 221 | $1,856 |
| 2025-10-06 | BICYCLE THERAPEUTICS PLC (BCYC) | CHIEF ACCOUNTING OFFICER | Sell | 103 | $866 |
| 2025-07-07 | BICYCLE THERAPEUTICS PLC (BCYC) | CHIEF ACCOUNTING OFFICER | Sell | 206 | $1,461 |
| 2025-07-07 | BICYCLE THERAPEUTICS PLC (BCYC) | CHIEF ACCOUNTING OFFICER | Sell | 100 | $744 |
| 2025-04-04 | BICYCLE THERAPEUTICS PLC (BCYC) | CHIEF ACCOUNTING OFFICER | Sell | 109 | $815 |
| 2025-04-04 | BICYCLE THERAPEUTICS PLC (BCYC) | CHIEF ACCOUNTING OFFICER | Sell | 210 | $1,684 |
Source: SEC Form 4 filings · as of 2026-07-07